Robot-assisted navigation in atrial fibrillation ablation—Of any benefits?  by Petrů, Jan & Škoda, Jan
Available online at www.sciencedirect.comjournal homepage: www.elsevier.com/locate/crvasa
c o r e t v a s a 5 4 ( 2 0 1 2 ) e 4 0 8 – e 4 1 30010-8650/$ - see fro
http://dx.doi.org/10
nCorresponding a
E-mail address:Review Article—Special issue: Atrial FibrillationRobot-assisted navigation in atrial fibrillation
ablation—Of any benefits?Jan Petru˚n, Jan Skodaˇ
Department of Cardiology, Na Homolce Hospital, Prague, Czech Republica r t i c l e i n f o
Article history:
Received 23 November 2012
Received in revised form
27 November 2012
Accepted 27 November 2012
Available online 29 November 2012
Keywords:
Atrial fibrillation
Catheter ablation
Remote navigationnt matter & 2012 The Cze
.1016/j.crvasa.2012.11.016
uthor. Tel.: þ420 7372123
jan.petru@homolka.cz (Ja b s t r a c t
In recent years, catheter ablation has been established as a safe and effective treatment for
atrial fibrillation (AF). The benefits of robotic catheter navigation technology and techniques for
AF ablation are currently a frequent topic of discussion. Most clinical trials have suggested that
robotic ablation is (at least) as effective as the manual approach. The most important potential
advantages of robotic ablation include excellent catheter stability and accuracy of its move-
ment, reduced fluoroscopic time, catheter contact monitoring, improved comfort of the operator
during the procedure as they can sit most of the time unexposed to radiation and, last but not
least, a very short learning curve potentially allowing for more complicated procedures
(persistent forms of AF, structural ventricular tachycardias, congenital heart disease).
& 2012 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o. All
rights reserved.
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The ultimate aims of robot-assisted technologies establishing
in branches of medicine include increased efficacy, accuracych Society of Cardiology.
99.
. Petru˚).and safety of the procedure and, also, standardization of the
course of the procedure. However, use of these procedures in
clinical practice is often hampered by lack of funds. Robotic
systems were marketed several years ago and are currentlyPublished by Elsevier Urban & Partner Sp.z o.o. All rights reserved..
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safety and increase the efficacy of the procedure also in
catheter ablation and, hence, catheter-based management of
AF [1]. Despite initial enthusiasm, operators continue to
consider manual catheter ablation the gold standard.2. Catheter ablation of atrial fibrillation
The number of catheter ablation procedures for paroxysmal or
chronic AF has been substantially increasing in recent years.
The reasons include increasing numbers of patients who
develop this arrhythmia (a prevalence of 1.5–2%) [2,3] and, also,
the outcomes of recent clinical trials clearly favoring catheter-
based treatment over pharmacotherapy. Their results have
been incorporated into the current guidelines of the European
Society of Cardiology (last updated in August 2012) [3].
Although the success rate of catheter-based treatment of AF
is high (65–90% absence of AF at 12 months post-ablation
[4–6,25]), the procedure is still plagued by numerous pitfalls for
the patient and operator alike. The procedure is a complex and
not only time-consuming one (overall duration 2–4–6 h) and
always based on so-called electrical isolation of all pulmonary
veins. The success of ablation is dependent on a variety of
factors such as the type of the arrhythmia to be managed
(paroxysmal vs. persistent or long-lasting persistent ones), left
atrial anatomy and size, the ablation strategy chosen (pulmon-
ary vein isolation and/or, alternatively, the connecting lines in
left and right atria), source of ablation energy (radiofrequency
current, laser, cryothermia, etc.) and, also importantly, on the
center’s/operator’s experience [7]. Although various types of
imaging techniques are available to the physician performing
ablation to manipulate with catheters in the left ventricle
[three-dimensional (3D) mapping systems, intracardiac ultra-
sound, integrated CT/MR scan and, most recently, also rota-
tional CT angiography], fluoroscopy continues to be an
absolutely irreplaceable technique for a number of reasons.
Exposure times of about 10–30–50min represent an non-
negligible radiation load for the operator and patient and are
more than three times longer compared with those of common
procedures such as atrial flutter ablation [8,9]. On top of this,Fig. 1 – A Stereotaxis system featuring two permanent
magnets generating a magnetic field in the patient’s body
for remote-control catheter navigation.the patient may experience various side effects with complica-
tions reported in up to 5% of cases! [2].
In light of the above, ideal ablation procedures would be short,
100% effective both acutely and particularly in the long term,
devoid of risk and, not requiring the use of x-ray radiation.
Admittedly, despite the impressive technological advances and
advent of robot-assisted ablation procedures, discussed in more
detail below, we are still a long way to the above ideal.3. Current robotic technologies
Currently, the two most widely used robotic navigation systems
in clinical practice operate on completely different principles of
catheter navigation. These are Niobe (I, II, Epoch upgrade)
developed by Stereotaxis, Inc. (St. Louis, Missouri, USA) using
the magnetic field to navigate the catheter, and the Sensei
system (HansenMedical Inc., Mountain View, CA, USA) operating
on the electromechanical principle (see below). Recently, two
more devices put on the market include the robotic navigation
CGCI system (Magnetecs, Inc., Inglewood, CA, USA) and Amigo
(Catheter Robotics, Inc., New Jersey, USA); however, the body of
clinical data currently available for the latter two systems is not
large enough to allow for their critical evaluation.3.1. Niobe I, II, and Epoch (Stereotaxis, Inc.)
The Niobe system features two giant permanent magnets creat-
ing around andwithin the patient’s body on the operating table a
magnetic field of 0.08–0.1 T (Fig. 1). The direction and movement
of a custom-made catheter, equipped with a miniature magnet
on its tip, are determined by the magnetic field vector. The vector
is changed by the operator moving a computer mouse thus
advancing the catheter as necessary to the point in the cardiac
chambers. Forward and backward movement of the catheter is
controlled by a miniature motor (V CAS). Catheter contact with
tissue is visualized indirectly, through a continuous curve show-
ing catheter deviation from the direction relative to the pre-
defined vector. The Stereotaxis device is compatible with both
basic 3D imaging systems (CARTO, NavX navigation systems).
Apart from ablation in all cardiac chambers and the pericardial
space, it can also be used to implant left ventricular leads and
perform percutaneous coronary interventions [10]. The latest
upgrade, the Epoch, has dramatically improved the speed of
catheter navigation (a response time of 0.125 s), which means
virtually real-time visualization of the catheter movement on the
computer display as the catheter is being deployed in the heart.
In addition to the ablation catheter, mechanical movement,
rotation, and flexion of a 13F supporting sheath in the left atrium
(and, if needed, also the diagnostic spiral ‘‘lasso’’ catheter
inserted into the individual pulmonary veins to document their
electrical isolation) can also be controlled by an integrated
joystick potentially affording increased ablation catheter contact
(see below).
The only health care facility in the Czech Republic with a
magnetic remote control navigation system currently in
clinical use is Prague, Na Homolce Hospital.
Fig. 2 – A Sensei system (Hansen Medical). (A) Robotic arm with catheter sheath in the right femoral vein. (B) Workstation
with a several monitors and an intuitively controlled lever joystick. (C) Joystick for catheter movement control. (D) A NavX
map of the left atrium with ablations made in the left atrium.
Fig. 3 – A CGCITM – catheter guidance control and imaging
system (Magnetecs) – a schematic.
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The Sensei system, operating on the electromechanical princi-
ple, consists of three main components: (1) a robotic arm, (2) a
system of two telescopic and flexible sheaths with a catheter
inside, and (3) a workstation with monitors and a special lever
controller (Fig. 2). The system is again compatible with both 3D
imaging systems. Throughout the procedure, the operator is
seated and intuitively manipulates with the lever controller
within space; the controller movements are transmitted via the
robotic arm to a sheath, resp. a catheter. While originally
developed primarily for AF ablation, the device has been in
recent years also employed for ventricular arrhythmia ablationprocedures. As the system of sheaths with the ablation catheter
is fairly rigid, several cases of cardiac tamponade have been
reported before adding a system measuring contact of the
catheter tip with the cardiac wall (IntelliSense) [8]. The degree
of contact is shown both visually in graphic form on the display
and, in a tactile manner, as vibrations of the lever mechanism
when the preset level of contact has been exceeded.
By the end of 2011, over 8000 procedures were performed
using this remote-control navigation system all over the
world! By March 2012, a total of 93 robotic systems have
been installed worldwide, of this number, three are in use in
the Czech Republic (Institute for Clinical and Experimental
Medicine, Prague; Na Homolce Hospital, Prague, and Cˇeske´
Budeˇjovice Hospital).
3.3. CGCITM—Catheter Guidance Control and Imaging
system (Magnetecs)
This device again operates on the magnetic field principle.
It is composed by a system of 8 electromagnets generating a
variable magnetic field of 0.1–0.2 T (Fig. 3). The advantage of
the variable electromagnetic field is that it allows not only to
bend the catheter; the catheter can also be rotated along its
longitudinal axis; the type of contact with the cardiac wall
can also be chosen. The catheter moves faster than with the
Stereotaxis device and allows to perform what is called
‘‘automated’’ ablation at sites predefined in a 3D electroana-
tomical map (NavX). Initial clinical experience was reported
already in 2010 after the device had been put into service
in Hospital Universitario la Paz in Madrid, Spain; plans are
for the installation of additional devices throughout the
world including, again, the Czech Republic (Na Homolce
Hospital).
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Another robotic system operating, similarly to the Sensei
device, on the electromechanical principle is the Amigo.
Using this device, a standard ablation catheter is advanced
into a custom-made steerable sheath remotely and intuitively
manipulated via a manual controller out of the reach of x-ray
radiation. The system is very simple and, again, fully compa-
tible with 3D imaging software. The first ablation procedure
was performed in Leicester, UK, in 2010.4. Are there then any obvious benefits of
robot-assisted ablation over manual ablation?
Yes, there are; at least some of them will be highlighted in the
lines below.1. Each robot-assisted catheter movement (whether using
magnetic or electromechanical navigation) is most accu-
rate and standardized so that it is virtually independent of
the operator’s skills and dexterity, which explains why the
learning curves for either system are comparable with and
much shorter than the learning curves for manual abla-
tion, as the latter is extremely dependent on the operator’s
experience. Standard results have been reported after an
approximate 20 procedures [11,12,14].2. Both systems have been shown to offer very good catheter
stability in otherwise difficult-to-access sites of the left
atrium. The Hansen system has the clear advantage of
direct mechanical monitoring of catheter contact with the
cardiac wall resulting in increased efficacy in creating
ablation lesions thereby increasing safety of the procedure
[8,12]. Based on the above, one would expect shorter
duration of ablation and the whole procedure. Still, most
studies comparing manual and electromechanical robotic
navigation suggest that robot-assisted procedures do not
actually make ablation and procedural time shorter
[8–10,12,13]. Still worse results in this respect have been
reported for magnetic navigation. Despite stable contact
between the catheter and cardiac tissue, the very soft
ablation catheter in a relatively weak electromagnetic field
(0.08–0.1 T) fails to achieve adequate contact; the result is
longer ablation time and higher energy requirements
[7,11,15,17]. Accordingly, total procedural time also tends
to be longer as against manual ablation, partly due to the
longer patient prepping (the same is true of electromagnetic
navigation). A meta-analysis by Bradfield (PACE, 2012, eval-
uating 6 comparative studies) showed that while the acute
success rate of pulmonary vein isolation by magnetic
navigation is significantly inferior (92% vs. 97% for manual
ablation; po0.01), whereas their intermediate outcomes are
comparable (70% and 69%, respectively). The weak correla-
tion between acute success rates and intermediate out-
comes may be due to the complexity of mechanisms of AF
and the relatively frequent switch to manual ablation in the
magnetic navigation group [16].Whether or not the recently
installed new models using magnetic navigation (Epoch)
with a stronger magnetic field and faster navigation, featur-
ing a remote-control deflectable sheath for the ablationcatheter (potential for increased contact, its continuity and,
eventually, stability) and remote-control spiral catheter
with a single joystick will improve the outcome is only to
be seen.3. Another advantage of robot-assisted navigation systems is
reduction of radiation exposure both for the patient and,
particularly, for the physician. Fluoroscopic times for AF
ablation vary over a wide range from 5 to 50 min (depend-
ing on the type of arrhythmia, ablation technique, experi-
ence and routine of the center). The overwhelming
majority of clinical trials with remote navigation have
demonstrated a significant reduction in fluoroscopic times
compared with manual ablation [7–9,11,12,15,23]. Just an
example, in a study published by Di Biase in 2009, the
fluoroscopic time in the Sensei robotic navigation group
was almost 10 min shorter (48.9724.4 vs. 58.4720.1 min;
po0.001) as against manual ablation [12]. Similar results
were reported by Steven with the difference in total
fluoroscopic exposure being 972.1 vs. 2276.5 min
(po0.001) [9]. While no randomized trials with magnetic
navigation in the treatment of AF have been published to
date [16], most papers suggest a decrease in fluoroscopic
time by about 50% (De Costa) [18]. This is supported by a
retrospective analysis published by Arya in 2011 demon-
strating a significant reduction in this parameter
(34.5715.1 vs. 13.777.8 mins; po0.0001) in the group with
ablation using magnetic navigation [15].4. A definite advantage of magnetic navigation is that it is
safe. The number of serious complications such as cardiac
tamponade occurring as it does during AF ablation –
according to Cappato – in an approx. 1% [2], is significantly
lower compared with manual ablation and electromecha-
nical robotic navigation [16,19]. The distal magnetic tip of
the catheter is very soft (likened to boiled spaghetti by
some), making the risk of cardiac wall perforation extre-
mely low. There may have been only two reports of
radiofrequency ablation-associated cardiac tamponade
with this catheter. The safety of magnetic navigation has
been highlighted by the above study of Arya reporting
rates of periprocedural complications of 3.8% for manual
ablation (including pericardial effusion in 2.4% of patients)
vs. 1.4% associated with the use of the Niobe system [15].5. According to currently available data, the success rates of
robotic techniques (acute and long-term outcomes) fully
compare with those of manual ablation procedures
[8,22,26–28]. This was reported in the studies assessing
magnetic navigation by Katsiyiannis (20 patients in the
magnetic navigation group), Arya (70 patients), Luthje
(54 patients), and Di Biase (45 patients) among others,
and electromagnetic navigation, e.g. studies published by
Steven (30 patients) or Di Biase (193 patients; the largest
published cohort published to date; the success rates in AF
termination over 14.171.3 months in the presence of
failed antiarrhythmic therapy was 85% and 81% in the
robotic navigation and manual ablation groups, respec-
tively). According to a study by Sorgente, the outcome of
magnetic navigation ablation compare with that reported
for cryoablation. Twelve months post-ablation, no episode
of AF following antiarrhythmic discontinuation was docu-
mented in 65.5%/19 patients receiving manual ablation,
Table 1 – A comparison of manual vs. robot-assisted navigation using the Niobe and Sensei systems.
Manual ablation Niobe Sensei
Purchase price þ þþþ þþ
Price per ablation þ þþ þþ
Acute success rate þþþ þþþ þþþ
Long-term success rate þþ þþ þþ
System portability þþþ 0 þþ
Fluoroscopy time reduction þ þþþ þþþ
Learning curve Relatively long Short Short
Catheter stability þ þþþ þþþ
Comfort of procedure þ þþþ þþþ
c o r e t v a s a 5 4 ( 2 0 1 2 ) e 4 0 8 – e 4 1 3e41266.7%/20 patients with magnetic navigation ablation, and
in 65.7%/23 patients having cryoballoon ablation. Using
the above techniques, pulmonary vein isolation was
invariably obtained in 100% of cases [20].5. Our own experience at Na Homolce
Hospital
In our hospital, both robotic navigation systems have been in
use since 2007 so our body of experience is relatively large.
In recent years, remote control navigation catheter ablation
procedures are performed mainly in patients with persistent
or long-lasting persistent AF. The implication is that the
procedure involve, in the vast majority of cases, pulmonary
vein isolation complemented with creating linear lesions in
the left or right atrium. With these prolonged procedures, the
disadvantage of a longer patient prepping is outbalanced by
higher comfort during ablation, safety of the procedure, and
reduced radiation load. In our group of long-lasting persistent
AF over the 2009–2011 period, remote control navigation
catheter ablation was used exclusively as the first procedure
in 68 patients. Mean duration of arrhythmia was 4.8 years
(1–12 years). Regardless of the device employed (Niobe, 20
procedures; Sensei, 48 procedures), the typical set of lesions
involved pulmonary vein isolation, mitral isthmus ablation,
roof line, coronary sinus ablation, and tricuspid-caval isth-
mus ablation. Pulmonary vein isolation was accomplished in
100% of cases with sinus rhythm restored in all patients,
whether by electrical cardioversion or by ablation (13%).
Atrial fibrillation termination by ablation predicted a high
success rate of the primary ablation (75%). No differences in
acute or long-term outcomes were observed between the two
techniques of remote control navigation. In cases where the
complete set of lesions with verification of bidirectional
blocks in lines were made during the first procedure, the
success rates at an average 11.5 months were 63% and 77%
after the first and second ablation procedures, respectively.
Our follow-up documented an acceptably low number of
episodes of residual atrial macro-reentry tachycardia in 9
(13.2%) patients.
A serious complication was experienced by two patients
(both in the Sensei group). One patient developed hemoper-
icardium requiring pericardiac puncture and drainage.
The other was a hypertensive patient dying suddenly (from
full health) on day 3 post-ablation of extensive hemorrhagicstroke while receiving adequate anticoagulation. A perfusion
CT scan did not document cerebral hemorrhage within the
region of potential embolism so any relation with the proce-
dure is not straightforward.6. Drawbacks of robotic navigation
Last but not least, some disadvantages and ‘‘cons’’ of remote
navigation systems should be acknowledged.
A clear con is the purchase price of robotic systems (e.g.,
the Stereotaxis system is priced at about 2 million euros);
likewise, the cost of a single procedure compared with
manual ablation is higher by tens of thousands of Czech
crowns. Magnetic navigation systems (Stereotaxis, Magne-
tecs) are floor anchor fixed in the lab; hence, they are not
portable. With robotic ablation procedures, patient prepping
is somewhat longer which may reflect in prolonged overall
duration of the procedure. Another disadvantage is the loss of
direct communication with the patient (lying on the operat-
ing table in a room other than where the operator’s work-
station is placed); this lack of communication must be made
up for by a third person. A drawback of the robotic Sensei
system is the sheath size (outer dimension 14F), which may
result in more frequent vascular complications in the groins.
While a pacemaker or an implantable cardioverter/defibrilla-
tor per se is not a contraindication, the devices have to be re-
programmed before and after the procedure as the magnetic
field activates the asynchronous mode, and there have also
been reports of transient changes in the lead pacing proper-
ties [21,24].
As no comparison of the two robotic systems has been
made in a randomized trial to date, they can only be
evaluated using indirect parameters (see Table 1).7. Conclusion
The benefits of robotized techniques for catheter-based abla-
tion procedures are unquestionable. In general, compared
with manual ablation, robotic navigation in catheter-based
management of atrial fibrillation makes catheter movement
more accurate and standardized, is associated with a shorter
learning curve, significantly reduces radiation exposure
(of the patient and operator alike), and provides the physician
performing a demanding procedure which takes several
c o r e t v a s a 5 4 ( 2 0 1 2 ) e 4 0 8 – e 4 1 3 e413hours to complete with greater comfort. On the other hand,
use of robotic navigation has not been conclusively shown to
improve acute and long-term success rates of atrial fibrilla-
tion ablation (the outcomes are fully comparable). Major
drawbacks of robot-assisted procedures include that they
are on average more costly and time-consuming. Nonethe-
less, remote-control technology is a dynamically developing
field (stability of 3D imaging, increase in continuous contact,
quick control) thus no doubt holding promise, particularly for
complex, time-consuming procedures.
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